The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosis

Medical Decision Making

Volumn 22, Issue 6, 2002, Pages 506-513

  Prosser, Lisa A ^a,d   Kuntz, Karen M ^b   Bar Or, Amit ^c   Weinstein, Milton C ^b  

^a HARVARD PILGRIM HEALTH CARE   (United States)

^b HARVARD CENTER FOR RISK ANALYSIS   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adherence; Compliance; Multiple sclerosis; Risk attitude; Treatment choice

Indexed keywords

BETA INTERFERON; GLATIRAMER;

ADULT; ARTICLE; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; HEALTH STATUS; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PATIENT ATTITUDE; PATIENT COMPLIANCE; RELAPSE; REMISSION; RISK; SIDE EFFECT;

ADJUVANTS, IMMUNOLOGIC; ADULT; ATTITUDE TO HEALTH; DECISION MAKING; FEMALE; HUMANS; INTERFERON-BETA; LOGISTIC MODELS; MALE; MASSACHUSETTS; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PEPTIDES; RISK ASSESSMENT; RISK-TAKING;

EID: 0036848951     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X02238299     Document Type: Article

References (35)

1. Simons MR. Interventions related to compliance. Nurs Clin North Am. 1992;27(2):477-94.
2. Wright EC. Non-compliance - Or how many aunts has Matilda? Lancet. 1993;342(8876):909-13.
3. Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med. 1997;102(2A):43-9.
4. Hoover H. Compliance in hemodialysis patients: A review of the literature. J Am Diet Assoc. 1989;89:957-9.
5. Turner BJ, Newschaffer CJ, Zhang D, Cosler L, Hauck WW. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care. 2000;38(9):911-25.
6. Winickoff RN, Murphy PK. The persistent problem of poor blood pressure control. Arch Intern Med. 1987;147:1393-6.
7. Cramer JA. Compliance with contraceptives and other treatments. Obstet Gynecol. 1996;88:4S-12S.
8. Neilley LK, Goodin DS, Goodkin DE, Hauser, SL. Side effect profile of interferon beta-1b: Results of an open label trial. Neurology. 1995;46:552-4.
9. Mohr DC, Goodkin DE, Likosky W, et al. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: Relationship to adherence to treatment. Mult Scler. 1996;2:222-6.
10. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol. 1996;39:285-94.
11. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology. 1995;45:1277-85.
12. Johnson KP, Brooks BR, Cohen JA, et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology. 1995;45:1268-76.
13. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383-6.
14. McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N Engl J Med. 1978;299(25):1397-1401.
15. Stiggelbout AM, Keibert GM, Keivit J, Leer JWH, Stoter G, deHaes JCJM. Utility assessment in cancer patients: Adjustment of time trade-off scores for the utility of life years and comparison with standard gamble scores. Med Decis Making. 1994;14:82-90.
16. Raiffa H. Decision Analysis: Introductory Lectures on Choices Under Uncertainty. Reading (MA): Addison-Wesley; 1968.
17. Stiggelbout AM, Keibert GM, Keivit J, Leer JWH, Stoter G, deHaes JCJM. Utility assessment in cancer patients: Adjustment of time trade-off scores for the utility of life years and comparison with standard gamble scores. Med Decis Making. 1994;14:82-90.
18. Miyamoto JM, Eraker SA. Parameter estimates for a QALY utility model. Med Decis Making. 1985;5(2):191-213.
19. Pliskin JS, Shepard DS, Weinstein MC. Utility functions for life years and health status. Operations Research. 1980;28(1):206-24.
20. Sumner W, Nease RF, Littenberg B. Status report on automated utility assessment with U-Titer. Med Decis Making. 1993;13:390.
21. Von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. Princeton (NJ); Princeton University Press; 1944.
22. StataCorp. Stata Statistical Software: Release 5.0. College Station (TX): Stata Corporation; 1997.
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology. 1983;33:1444-52.
24. Stata Reference Manual. Vol. 2. College Station (TX): Stata Press; 1999.
25. Nightingale SD. Risk preference and laboratory test selection. J Gen Intern Med. 1998;2:25-8.
26. Nightingale SD. Risk preference and laboratory use. Med Decis Making. 1987;7:168-73.
27. Nightingale SD. Risk preference and admitting rates of emergency room physicians. Med Care. 1988;26:84-7.
28. Nightingale SD, Grant M. Risk preference and decision making in critical care situations. Chest. 1988;93:684-7.
29. Kahneman D, Tversky A. Prospect theory: An analysis of decision under risk. Econometrica. 1979;47(2):263-91.
30. Von Winterfeldt D, Edwards W. Decision Analysis and Behavioral Research. New York: Cambridge University Press; 1986.
31. Bell DE, Raiffa H. Marginal value and intrinsic risk aversion. In: Bell DE, Raiffa H, Tversky A, editors. Decision Making: Descriptive, Normative, and Prescriptive Interactions. New York: Cambridge University Press; 1988.
32. Zeelenberg M, Beattie J, Van der Plight J, DeVries NK. Consequences of regret aversion: Effects of expected feedback on risky decision making. Org Behav Hum Decis Proc. 1996;65:148-58.
33. Beattie J, Baron J, Hershey JC, Spranca MD. Psychological determinants of decision attitude. J Behav Decis Making. 1994;7:129-44.
34. Lopes L. Risk and distributional equity. J Exp Psychol Hum Percept Perform. 1984;10:465-85.
35. Lopes LL. Re-modeling risk aversion: A comparison of Bernoullian and rank dependent value approaches. In: von Furstenberg, GM, editor. Acting Under Uncertainty: Multidisciplinary Conceptions. Norwell (MA): Kluwer Academic; 1990.